IDiyas

For the Inventor, By the Inventor

Barto, PA, United States of America

Kevin F Gilbert

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 4.5

ph-index = 6

Forward Citations = 189(Granted Patents)


Location History:

  • Bechtelsville, PA (US) (1993 - 1998)
  • Barto, PA (US) (2001 - 2017)

Company Filing History:

goldMedal6 out of 4,770 
 
Merck + Co., Inc.
 patents
silverMedal4 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents

Years Active: 1993-2017

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 9624208 - Benzoxazolinone compounds with selective activity in voltage-gated sodium channels (2017-04-18),
2. 9273040 - Benzoxazolinone compounds with selective activity in voltage-gated sodium channels (2016-03-01),
3. 8815902 - Tetrahydroquinoline amide M1 receptor positive allosteric modulators (2014-08-26),
4. 8461107 - HCV NS3 protease inhibitors (2013-06-11),
5. 6387893 - Spirotricyclic substituted azacycloalkane derivatives and uses thereof (2002-05-14),
6. 6326372 - Lactam and cyclic urea derivatives useful as alpha 1a adrenoceptor antagonists (2001-12-04),
7. 5756504 - Tocolytic oxytocin receptor antagonists (1998-05-26),
8. 5693643 - Hydantoin and succinimide-substituted derivatives of (1997-12-02),
9. 5464788 - Tocolytic oxytocin receptor antagonists (1995-11-07),
10. 5204349 - Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin (1993-04-20),

Title: Kevin F Gilbert: Innovator in Neuropathic Pain Treatment

Introduction

Kevin F Gilbert is a notable inventor based in Barto, PA (US), recognized for his significant contributions to the field of pharmaceuticals. He holds a total of 10 patents, showcasing his innovative approach to addressing medical challenges.

Latest Patents

Among his latest patents are the benzoxazolinone compounds with selective activity in voltage-gated sodium channels. These compounds, represented by Formula A, exhibit properties for blocking Na1.7 ion channels found in peripheral and sympathetic neurons. The patents also describe pharmaceutical formulations that incorporate these compounds or their salts, along with methods for treating neuropathic pain disorders.

Career Highlights

Kevin has had a distinguished career, working with prominent companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His work has significantly impacted the development of treatments for neuropathic pain, demonstrating his commitment to advancing medical science.

Collaborations

Throughout his career, Kevin has collaborated with esteemed colleagues, including Ben E Evans and Mark G Bock. These partnerships have contributed to the success of his innovative projects and patents.

Conclusion

Kevin F Gilbert's work in developing benzoxazolinone compounds highlights his dedication to improving treatments for neuropathic pain. His contributions to the pharmaceutical industry continue to make a significant impact.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…